INDOGULF CROPSCIENCES Q2 FY27: EBITDA UP 27% YOY, PAT UP 24%; MARGINS EXPAND 300 BPS, NEW DRY FLOWABLE PLANT & GLOBAL EXPANSION PLANNED

• H2 FY27 Outlook: Management expects continued profitable growth during H2, supported by improving business momentum, higher-value products and expanding international opportunities • Quarterly Results: Revenue increased 3% YoY and 52% QoQ to ₹256 Cr, while EBITDA surged 27% YoY to ₹41 Cr • Profitability: PAT increased 24% YoY to ₹26 Cr, supported by lower finance costs and improved operating efficiency • Margin Expansion: EBITDA margin improved to 15.9% from approximately 12.9% YoY, expanding 300 bps, while PAT margin increased to 10% from approximately 8.3% • Sequential Recovery: EBITDA increased to approximately ₹41 Cr from ₹9 Cr QoQ, while PAT increased to approximately ₹26 Cr from ₹2 Cr QoQ, based on rounded H1 figures • Manufacturing Expansion: Setting up a new dry flowable plant to strengthen manufacturing capabilities and expand its crop protection portfolio • Export Expansion Plans: Targeting increased presence across Latin America, Africa, Southeast Asia and the Middle East • Biologicals Expansion: Strengthening biological crop protection and plant nutrients portfolio to capture growing demand for sustainable agricultural solutions • High-Margin Product Strategy: Increasing contribution from value-added products and improving product mix to support higher margins and profitability • Global Business Opportunities: Management sees growing export opportunities as international customers diversify sourcing towards reliable Indian agrochemical manufacturers • H1 Performance: Revenue declined 3% YoY to ₹424 Cr, while EBITDA increased 20% to ₹50 Cr and PAT grew 14% to ₹28 Cr • H1 Margin Performance: EBITDA margin improved to 11.8% from approximately 9.6% YoY, while gross margin expanded to 29% from 26% • Distribution Network: Operates four manufacturing facilities, with 300+ products, 1,000+ registrations, presence in 36+ countries and over 7,500 distributors • Future Growth Strategy: Focused on new manufacturing capacity, biologicals, specialty plant nutrients, international market expansion and improving operating efficiency • Key Challenges: Weak monsoon conditions and subdued Kharif demand affected H1 revenue growth despite improving profitability • FY27 Guidance & Capex: Management expressed confidence in H2 growth but did not disclose quantified FY27 revenue growth, EBITDA margin, capex budget or dry flowable plant commissioning timeline

INDOGULF CROPSCIENCES LTD

← Back to feed